544673 — Modern Diagnostic & Research Centre Income Statement
0.000.00%
- IN₹1.18bn
- IN₹1.47bn
- IN₹779.45m
- 58
- 36
- 62
- 53
Annual income statement for Modern Diagnostic & Research Centre, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 602 | 563 | 671 | 779 |
| Cost of Revenue | ||||
| Gross Profit | 389 | 388 | 495 | 591 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 579 | 611 | 600 | 642 |
| Operating Profit | 23.3 | -48.6 | 71.3 | 138 |
| Total Net Non Operating Interest Income / Expense | ||||
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 11.4 | -59.4 | 68.6 | 127 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -14.5 | -57.3 | 57.9 | 89.7 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -14.5 | -57.3 | 57.9 | 89.7 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -14.5 | -57.3 | 57.9 | 89.7 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.961 | -3.82 | 3.84 | 5.94 |